<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/21/1524" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/21/1524/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/21/1524/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_1524"><akn:num>1524</akn:num><akn:heading>Authorization of appropriations</akn:heading><akn:content><akn:p>§ 1524. Authorization of appropriations(a) In generalThere is authorized to be appropriated to the Office of National Drug Control Policy to carry out this subchapter $99,000,000 for each of fiscal years 2018 through 2023.


(b) Administrative costsNot more than 8 percent of the funds appropriated to carry out this subchapter may be used by the Office of National Drug Control Policy to pay administrative costs associated with the responsibilities of the Office under this subchapter.


(Pub. L. 100–690, title I, § 1024, as added Pub. L. 105–20, § 2(a)(2), June 27, 1997, 111 Stat. 226; amended Pub. L. 107–82, § 1(b), (c), Dec. 14, 2001, 115 Stat. 817; Pub. L. 109–469, title VIII, § 801, Dec. 29, 2006, 120 Stat. 3535; Pub. L. 115–271, title VIII, § 8203(a)(3)(A), (b)(3), formerly § 8203(a)(4)(A), (b)(3), Oct. 24, 2018, 132 Stat. 4111, renumbered Pub. L. 116–74, § 2(c)(1)(A)(i)(IV), Nov. 27, 2019, 133 Stat. 1157; Pub. L. 116–74, § 2(c)(1)(A)(i)(V), (ii)(II), Nov. 27, 2019, 133 Stat. 1157.)

Editorial Notes
Amendments2019—Pub. L. 116–74, § 2(c)(1)(A)(ii)(II), made technical amendment to directory language of Pub. L. 115–271, § 8203(b)(3). See 2018 Amendment note below.
Pub. L. 116–74, § 2(c)(1)(A)(i)(V), made technical amendment to directory language of Pub. L. 115–271, § 8203(a)(3)(A). See 2018 Amendment note below.
2018—Pub. L. 115–271, § 8203(b)(3), as amended by Pub. L. 116–74, § 2(c)(1)(A)(ii)(II), added subsecs. (a) and (b) and struck out former subsecs. (a) and (b), which related to authorization of appropriations and administrative costs, respectively.
Pub. L. 115–271, § 8203(a)(3)(A), formerly § 8203(a)(4)(A), as renumbered and amended by Pub. L. 116–74, § 2(c)(1)(A)(i)(IV), (V), amended directory language of Pub. L. 109–469, § 801. See 2006 Amendment notes below.
2006—Subsec. (a)(11) to (15). Pub. L. 109–469, § 801(a), as amended by Pub. L. 115–271, § 8203(a)(3)(A), added pars. (11) to (15).
Subsec. (b). Pub. L. 109–469, § 801(b), as amended by Pub. L. 115–271,</akn:p></akn:content><akn:subsection eId="subsec_1524_a"><akn:num>(a)</akn:num><akn:heading>In general</akn:heading><akn:content><akn:p>(a) In general There is authorized to be appropriated to the Office of National Drug Control Policy to carry out this subchapter $99,000,000 for each of fiscal years 2018 through 2023.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1524_b"><akn:num>(b)</akn:num><akn:heading>Administrative costs</akn:heading><akn:content><akn:p>(b) Administrative costs Not more than 8 percent of the funds appropriated to carry out this subchapter may be used by the Office of National Drug Control Policy to pay administrative costs associated with the responsibilities of the Office under this subchapter.</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>